Finance

Lists
Why is OKUR down ၄.၀၅%?
Dive Deeper
OKUR:NASDAQ
Onkure Therapeutics Inc
၂.၂၅ US$
-၄.၀၅%
(-၀.၀၉၅) 1D
၂.၂၅ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၁၄, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OKUR...
Open
၂.၂၉ US$
High
၂.၃၈ US$
Low
၂.၂၁ US$
Mkt. cap
၉.၀၉ ကုဋေ
Avg. vol.
၃.၂၄ သိန်း
Volume
၀.၀၀
52-wk high
၅.၃၈ US$
52-wk low
၂.၁၃ US$
EPS
-၃.၅၀ US$
Beta
၀.၁၂
Shares outstanding
၄.၀၅ ကုဋေ
No. of employees
၄၅
Open
၂.၂၉ US$
High
၂.၃၈ US$
Low
၂.၂၁ US$
Mkt. cap
၉.၀၉ ကုဋေ
Avg. vol.
၃.၂၄ သိန်း
Volume
၀.၀၀
52-wk high
၅.၃၈ US$
52-wk low
၂.၁၃ US$
EPS
-၃.၅၀ US$
Beta
၀.၁၂
Shares outstanding
၄.၀၅ ကုဋေ
No. of employees
၄၅
News stories
From web sources and news partners
https://www.dars.gov.et/
https://www.dars.gov.et/
·
ပြီးခဲ့သည့် ၂ လ
OnKure Therapeutics (OKUR) Rises 3.6% as Stock Approaches Key Resistance Level - Strangle Setup
About Onkure Therapeutics Inc
CEO-
Employees၄၅
Founded၂၀၁၁
Headquartersဘိုးလ်ဒါ, ကော်လိုရာဒိုပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to OKUR in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for OKUR in the last 3 months.
Highest
Current ၂.၂၅ US$
၂၁.၀၀ US$ (+၈၃၃.၃၃%)
Average
၁၇.၀၀ US$ (+၆၅၅.၅၆%)
Lowest
၁၄.၀၀ US$ (+၅၂၂.၂၂%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Biegler
Oppenheimer
Buy
Reiterated
၁၄.၀၀ US$
+၅၂၂.၂%
08/14/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
၁၄.၀၀ US$
+၅၂၂.၂%
08/14/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
၁၆.၀၀ US$
+၆၁၁.၁%
08/05/2026
Boris Peaker
JonesTrading
Hold
Maintained
-
-
08/05/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
၂၁.၀၀ US$
+၈၃၃.၃%
07/20/2026
Soumit Roy
JonesTrading
Buy
Maintained
၁၇.၀၀ US$
+၆၅၅.၆%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁.၁၉ ကုဋေ
၁.၀၇ ကုဋေ
၁.၁၇ ကုဋေ
၁.၂၆ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၅၉ သန်း
၃.၄၀ သန်း
၃.၉၁ သန်း
၄.၂၉ သန်း
Operating expense
၁.၅၅ ကုဋေ
၁.၄၁ ကုဋေ
၁.၅၆ ကုဋေ
၁.၆၉ ကုဋေ
Total operating expenses
၁.၅၅ ကုဋေ
၁.၄၁ ကုဋေ
၁.၅၆ ကုဋေ
၁.၆၉ ကုဋေ
Operating income
-၁.၅၅ ကုဋေ
-၁.၄၁ ကုဋေ
-၁.၅၆ ကုဋေ
-၁.၆၉ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၁.၄၇ ကုဋေ
-၁.၃၅ ကုဋေ
-၁.၅၂ ကုဋေ
-၁.၅၃ ကုဋေ
EBT excluding unusual items
-၁.၄၇ ကုဋေ
-၁.၃၅ ကုဋေ
-၁.၅၂ ကုဋေ
-၁.၅၃ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၄၇ ကုဋေ
-၁.၃၅ ကုဋေ
-၁.၅၂ ကုဋေ
-၁.၅၃ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၁.၀၉
-၀.၉၉
-၁.၁၁
-၀.၃၁
Interest and investment income
၈.၀၄ သိန်း
၆.၂၈ သိန်း
၄.၅၈ သိန်း
၁.၅၅ သန်း
Interest expense
-၂.၀၀ ထောင်
-၆.၀၀ ထောင်
-
-
Net interest expenses
၈.၀၂ သိန်း
၆.၂၂ သိန်း
၄.၅၈ သိန်း
၁.၅၅ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၅၄ ကုဋေ
-၁.၄၀ ကုဋေ
-၁.၅၅ ကုဋေ
-၁.၆၈ ကုဋေ
Gain or loss from assets sale
၂.၀၀ ထောင်
၄.၀၀ ထောင်
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ